Perspective Therapeutics (CATX) Preferred Dividend Payments (2010 - 2020)
Perspective Therapeutics' (CATX) quarterly Preferred Dividend Payments came in at $3000.0 in Q3 2020, little changed year-over-year from $3000.0 in Q4 2019, and little changed quarter-over-quarter from $3000.0 in Q2 2020.
Analysis
Perspective Therapeutics (CATX) Preferred Dividend Payments (2010 - 2020) Analysis & Trends
Perspective Therapeutics has disclosed Preferred Dividend Payments across 11 years of filings, most recently posting $3000.0 for Q3 2020.
- In Q3 2020, Preferred Dividend Payments changed 0.0% year-over-year to $3000.0; the TTM figure through Jun 2021 stood at $3000.0 (down 72.73% YoY), while the FY2021 annual figure was $3000.0, down 72.73% from the prior year.
- Preferred Dividend Payments came in at $3000.0 for Q3 2020 at Perspective Therapeutics, roughly flat from $3000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $3000.0 in Q1 2016 to a low of $2000.0 in Q4 2016.
- Average Preferred Dividend Payments over 5 years is $2842.1, with a median of $3000.0 recorded in 2016.
- Year-over-year, Preferred Dividend Payments tumbled 33.33% in 2016 and surged 50.0% in 2017.
- Over 5 years, Preferred Dividend Payments stood at $2000.0 in 2016, then surged by 50.0% to $3000.0 in 2017, then slumped by 33.33% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then surged by 50.0% to $3000.0 in 2020.
- Per Business Quant data, the three most recent Preferred Dividend Payments figures were $3000.0 in Q3 2020, $3000.0 in Q2 2020, and $3000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Perspective Therapeutics | 358.23 Mn | 358.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 3,000.00 |
| Dec 31, 2017 | 3,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 3,000.00 |
| Mar 31, 2017 | 3,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 3,000.00 |
| Mar 31, 2016 | 3,000.00 |
| Dec 31, 2015 | 3,000.00 |